NDC 64365-501-01 - Panretin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 64365-501
Requested NDC: 64365-501-01
Package NDCs from labels: 64365-501-01
Manufacturer: Ligand Pharmaceuticals Incorporated
Effective date: 2006-10-06
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Panretin - Ligand Pharmaceuticals Incorporated	Ligand Pharmaceuticals Incorporated	2006-10-06	HUMAN PRESCRIPTION DRUG LABELING

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
64365-501-01	Panretin	60 g in 1 TUBE	GEL	60		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
64365-501	PANRETIN (ALITRETINOIN) GEL [LIGAND PHARMACEUTICALS INCORPORATED]	1	1 package rows	20061114_9CF04DAD-E312-4B8F-A297-1E002D43E151.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
alitretinoin	ACTIVE INGREDIENT	1UA8E65KDZ	PANRETIN (ALITRETINOIN) GEL [LIGAND PHARMACEUTICALS INCORPORATED]	1
alitretinoin	ACTIVE MOIETY	1UA8E65KDZ	PANRETIN (ALITRETINOIN) GEL [LIGAND PHARMACEUTICALS INCORPORATED]	1
Butylated Hydroxytoluene	INACTIVE INGREDIENT		PANRETIN (ALITRETINOIN) GEL [LIGAND PHARMACEUTICALS INCORPORATED]	1
Dehydrated alcohol	INACTIVE INGREDIENT		PANRETIN (ALITRETINOIN) GEL [LIGAND PHARMACEUTICALS INCORPORATED]	1
Hydroxypropyl Cellulose	INACTIVE INGREDIENT		PANRETIN (ALITRETINOIN) GEL [LIGAND PHARMACEUTICALS INCORPORATED]	1
Polyethylene Glycol 400	INACTIVE INGREDIENT		PANRETIN (ALITRETINOIN) GEL [LIGAND PHARMACEUTICALS INCORPORATED]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
PANRETIN	ALITRETINOIN	Advanz Pharma (US) Corp.	49c16717-7d86-4257-80c9-baa1417e5555	2025-11-25	Warnings, Adverse reactions	Exact identifier rxcui: 213502 rxcui: 313847
9CF04DAD-E312-4B8F-A297-1E002D43E151			9CF04DAD-E312-4B8F-A297-1E002D43E151	2006-10-06	Warnings, Adverse reactions	Exact identifier spl id: 9CF04DAD-E312-4B8F-A297-1E002D43E151 spl set id: 9CF04DAD-E312-4B8F-A297-1E002D43E151

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.